ConductScience.org, home

Paper26316558

Evolving resistance among Gram-positive pathogens.

Munita JM and 2 others. Clin Infect Dis, 2015. Cited by 86 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Evolving resistance among Gram-positive pathogens. Papers, record 26316558. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26316558

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Evolving resistance among Gram-positive pathogens.
PubMed
Journal
Clin Infect Dis
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
86
iCite
Relative citation ratio, by iCite
3.67
iCite
Revised in PubMed
2022-04-08
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Munita JMJose M
2Bayer ASArnold S
3Arias CACesar A

Source PubMed

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Bacterial AgentsMajor topic
Drug Resistance, BacterialMajor topic
Drug Resistance, Multiple, BacterialMajor topic
Gram-Positive BacteriaMajor topic
Gram-Positive Bacterial InfectionsMajor topic
Animals
Evolution, Molecular
Humans
Mutation

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI039108NIAID NIH HHSUnited StatesR01AI039108PubMed and NIHNIH RePORTER
R01 AI093749NIAID NIH HHSUnited StatesR01AI093749PubMed and NIHNIH RePORTER
R01 AI39108-15NIAID NIH HHSUnited StatesR01AI391081PubMedNIH RePORTER

References72

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122,393,892Molecular mechanisms of β-lactam resistance in Streptococcus pneumoniae.Future Microbiol2012https://conductscience.org/library/papers/22393892PubMed
225,614,044Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study.J Antimicrob Chemother2015https://conductscience.org/library/papers/25614044PubMed
325,000,230Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.Microb Drug Resist2014https://conductscience.org/library/papers/25000230PubMed
422,398,650Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline.J Antimicrob Chemother2012https://conductscience.org/library/papers/22398650PubMed
523,478,959Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23478959PubMed
617,517,606Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing.Proc Natl Acad Sci U S A2007https://conductscience.org/library/papers/17517606PubMed
725,583,724
Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998.
Antimicrob Agents Chemother2015https://conductscience.org/library/papers/25583724PubMed
821,646,483Low fitness cost of the multidrug resistance gene cfr.Antimicrob Agents Chemother2011https://conductscience.org/library/papers/21646483PubMed
921,690,622Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.Clin Infect Dis2011https://conductscience.org/library/papers/21690622PubMed
1021,899,450Genetic basis for in vivo daptomycin resistance in enterococci.N Engl J Med2011https://conductscience.org/library/papers/21899450PubMed
1122,431,854Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections.Clin Infect Dis2012https://conductscience.org/library/papers/22431854PubMed
1225,355,940Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae.J Infect Dis2015https://conductscience.org/library/papers/25355940PubMed
1324,092,854A current perspective on daptomycin for the clinical microbiologist.Clin Microbiol Rev2013https://conductscience.org/library/papers/24092854PubMed
1422,664,970Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: revisiting daptomycin breakpoints.Antimicrob Agents Chemother2012https://conductscience.org/library/papers/22664970PubMed
1523,547,139Dissecting the mechanisms of linezolid resistance in a Drosophila melanogaster infection model of Staphylococcus aureus.J Infect Dis2013https://conductscience.org/library/papers/23547139PubMed
1618,257,700Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.Clin Infect Dis2008https://conductscience.org/library/papers/18257700PubMed
1723,896,478β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23896478PubMed
1819,680,247Waves of resistance: Staphylococcus aureus in the antibiotic era.Nat Rev Microbiol2009https://conductscience.org/library/papers/19680247PubMed
1912,234,875Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis.Antimicrob Agents Chemother2002https://conductscience.org/library/papers/12234875PubMed
2022,421,879The rise of the Enterococcus: beyond vancomycin resistance.Nat Rev Microbiol2012https://conductscience.org/library/papers/22421879PubMed

See all 72 references

Cited by58

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 86 citations.

PMIDTitleJournalYearIn PapersSource
41,987,840A New Preview of Antibiotic-resistant Spectrum in Community-acquired Pneumonia: A Cross-Sectional Study from Iraq.Open Respir Med J2026https://conductscience.org/library/papers/41987840PubMed
41,620,502Staphylococcus capitis strain producing dual bacteriocins, capidermicin and micrococcin P1, shows broad-spectrum antimicrobial activity.Sci Rep2026https://conductscience.org/library/papers/41620502PubMed
41,054,619LC-MS/MS Method for Simultaneous Quantification of Three Oxazolidinone Antimicrobials in Human Plasma: Application to Therapeutic Drug Monitoring.Drug Des Devel Ther2025https://conductscience.org/library/papers/41054619PubMed
40,787,034A Practice Primer and Update on Anti-Bacterial Resistance.Mo Med2025https://conductscience.org/library/papers/40787034PubMed
40,535,975Gram-positive ESKAPE pathogens in Germany: A comprehensive analysis of occurrence and resistance development in animal, food, and environmental sources.One Health2025https://conductscience.org/library/papers/40535975PubMed
40,529,959Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review.Ther Adv Infect Dis2025https://conductscience.org/library/papers/40529959PubMed
39,878,538Transition metal complexes: next-generation photosensitizers for combating Gram-positive bacteria.Future Med Chem2025https://conductscience.org/library/papers/39878538PubMed
39,766,587Evaluation of Antibiotic Resistance Mechanisms in Gram-Positive Bacteria.Antibiotics (Basel)2024https://conductscience.org/library/papers/39766587PubMed
39,726,767Unleashing nature's defense: potent antimicrobial power of plant extracts against oral pathogens and Streptococcus mutans biofilms.Front Oral Health2024https://conductscience.org/library/papers/39726767PubMed
39,682,751Perspectives on Microbiome Therapeutics in Infectious Diseases: A Comprehensive Approach Beyond Immunology and Microbiology.Cells2024https://conductscience.org/library/papers/39682751PubMed
39,464,831Drug Repurposing: Research Progress of Niclosamide and Its Derivatives on Antibacterial Activity.Infect Drug Resist2024https://conductscience.org/library/papers/39464831PubMed
39,274,926Investigation on the Synergy between Membrane Permeabilizing Amphiphilic α-Hydrazido Acids and Commonly Used Antibiotics against Drug-Resistant Bacteria.Molecules2024https://conductscience.org/library/papers/39274926PubMed
39,015,246Antibiogram of Bacteria Isolated from Bloodstream Infection-Suspected Patients at the University of Gondar Comprehensive Specialized Hospital in Northwest Ethiopia: A Retrospective Study.Int J Microbiol2024https://conductscience.org/library/papers/39015246PubMed
38,951,840Analysis of molecular epidemiological characteristics and antimicrobial susceptibility of vancomycin-resistant and linezolid-resistant Enterococcus in China.BMC Med Genomics2024https://conductscience.org/library/papers/38951840PubMed
38,920,588D-Glucose-Mediated Gold Nanoparticle Fabrication for Colorimetric Detection of Foodborne Pathogens.Biosensors (Basel)2024https://conductscience.org/library/papers/38920588PubMed
38,792,231Modeling of Effectiveness of N3-Substituted Amidrazone Derivatives as Potential Agents against Gram-Positive Bacteria.Molecules2024https://conductscience.org/library/papers/38792231PubMed
38,276,161Antibiotic Resistance to Molecules Commonly Prescribed for the Treatment of Antibiotic-Resistant Gram-Positive Pathogens: What Is Relevant for the Clinician?Pathogens2024https://conductscience.org/library/papers/38276161PubMed
38,275,314Progressive Design of a Ranatuerin-2 Peptide from Amolops wuyiensis: Enhancement of Bioactivity and In Vivo Efficacy.Antibiotics (Basel)2023https://conductscience.org/library/papers/38275314PubMed
36,995,227Top-Down Genomic Surveillance Approach To Investigate the Genomic Epidemiology and Antibiotic Resistance Patterns of Enterococcus faecium Detected in Cancer Patients in Arkansas.Microbiol Spectr2023https://conductscience.org/library/papers/36995227PubMed
36,742,328IgY antibodies: The promising potential to overcome antibiotic resistance.Front Immunol2023https://conductscience.org/library/papers/36742328PubMed

See all 58 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26316558

GET https://conductscience.org/api/papers/v1/26316558/references?page=2